Meyka Pro banner
Auddia Inc.

Auddia Inc. Fundamental Analysis (NASDAQ: AUUD)

AUUDNASDAQ
TechnologySoftware - Application
$1.32
$0.37(38.93%)
U.S. Market opens in 13h 44m

Auddia Inc. Fundamental Analysis (NASDAQ: AUUD)

Auddia Inc. (NASDAQ: AUUD) shows weak financial fundamentals with a PE ratio of -0.02, profit margin of 0.00%, and ROE of -2.33%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position875.97%
PEG Ratio-0.00
Current Ratio2.30

Areas of Concern

ROE-2.33%
Operating Margin0.00%
We analyze AUUD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -324.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-324.3/100

We analyze AUUD's fundamental strength across five key dimensions:

Efficiency Score

Weak

AUUD struggles to generate sufficient returns from assets.

ROA > 10%
-2.35%

Valuation Score

Excellent

AUUD trades at attractive valuation levels.

PE < 25
-0.02
PEG Ratio < 2
-0.00

Growth Score

Weak

AUUD faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

AUUD maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
2.30

Profitability Score

Weak

AUUD struggles to sustain strong margins.

ROE > 15%
-232.61%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is AUUD Expensive or Cheap?

P/E Ratio

AUUD trades at -0.02 times earnings. This suggests potential undervaluation.

-0.02

PEG Ratio

When adjusting for growth, AUUD's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Auddia Inc. at 0.08 times its book value. This may indicate undervaluation.

0.08

EV/EBITDA

Enterprise value stands at -1.59 times EBITDA. This is generally considered low.

-1.59

How Well Does AUUD Make Money?

Net Profit Margin

For every $100 in sales, Auddia Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-2.33 in profit for every $100 of shareholder equity.

-2.33%

ROA

Auddia Inc. generates $-2.35 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.35%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-37.73 in free cash annually.

$-37.73

FCF Yield

AUUD converts -1.08% of its market value into free cash.

-1.08%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.08

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.33

vs 25 benchmark

ROA

Return on assets percentage

-2.35

vs 25 benchmark

ROCE

Return on capital employed

-2.73

vs 25 benchmark

How AUUD Stacks Against Its Sector Peers

MetricAUUD ValueSector AveragePerformance
P/E Ratio-0.0235.33 Better (Cheaper)
ROE-232.61%731.00% Weak
Net Margin0.00%-130376.00% (disorted) Weak
Debt/Equity0.020.41 Strong (Low Leverage)
Current Ratio2.305.91 Strong Liquidity
ROA-234.94%243.00% Weak

AUUD outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Auddia Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Growth, Innovation, High Beta

EPS CAGR

N/A

Industry Style: Growth, Innovation, High Beta

FCF CAGR

N/A

Industry Style: Growth, Innovation, High Beta

Fundamental Analysis FAQ